Details for New Drug Application (NDA): 018471
✉ Email this page to a colleague
NDA 018471 describes OCUCLEAR, which is a drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional details are available on the OCUCLEAR profile page.
The generic ingredient in OCUCLEAR is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
The generic ingredient in OCUCLEAR is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
Summary for 018471
| Tradename: | OCUCLEAR |
| Applicant: | Bayer Healthcare Llc |
| Ingredient: | oxymetazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018471
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.025% | ||||
| Approval Date: | May 30, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
